Public Health Implications of Preventive Nutrition

  • Jeffrey B. Blumberg
Part of the Nutrition ◊ and ◊ Health book series (NH)


The recent debate about health care reform has focused largely on issues of equal access, cost containment, and delivery of primary care with some minor appreciation of the need for continued support for research and development. The central paradigm of this discussion is universal coverage and ways to finance it. Largely absent from consideration is the recognition that public health policies must drastically reduce the current disease-oriented treatment approach by encouraging significant changes in provider and consumer attitudes toward health promotion and health maintenance. Abundant evidence indicates that a health care system with a goal of promoting health and preventing illness will cost less than the present system, which basically operates to respond to the presence of illness with expensive diagnostic and therapeutic interventions. Consensus reports, like those from the US Surgeon General and National Research Council, clearly support the notion of preventive nutrition: that the most important choice people can make to influence their long-term health prospects is the choice of diet (1–3). Importantly, the modalities of this choice extend beyond a knowledgeable selection of food items and include nutrient enrichment, fortification, supplementation, and most recently, the potential of functional foods (4).


Coronary Heart Disease Health Care Expenditure Public Health Implication Gross National Product Multiple Risk Factor Intervention Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    US Surgeon General. Report on nutrition and health. Washington, DC: US Department of Health and Human Services, 1988.Google Scholar
  2. 2.
    National Research Council. Diet and health: implications for reducing chronic disease risk. Washington, DC: National Academy Press, 1989.Google Scholar
  3. 3.
    Health and Welfare Canada. Nutrition recommendations: the report of the Scientific Review Committee. Ottawa: Minister of Supply and Services, 1990.Google Scholar
  4. 4.
    Goldberg I. Functional foods: designer foods, pharmafoods, nutraceuticals. New York: Chapman & Hall, 1994.Google Scholar
  5. 5.
    National Research Council. Recommended dietary allowances. Washington, DC: National Academy Press, 1989.Google Scholar
  6. 6.
    US Department of Agriculture, Department of Health and Human Services. Nutrition and your health: Dietary guidelines for Americans. 3rd ed, 1990. [Home and Garden Bulletin No. 232]Google Scholar
  7. 7.
    US Department of Health and Human Services, National Cancer Institute, National Institutes of Health. Diet, nutrition and cancer prevention: a guide to food choices. Washington, DC: US Govermnent Printing Office, 1984. [NIH publication no. 85–2711]Google Scholar
  8. 8.
    Food and Nutrition Board, Institute of Medicine. How should the Recommended DietaryAllowances be revised? Washington, DC: National Academy Press, 1994.Google Scholar
  9. 9.
    National Center for Health Statistics. Healthy People 2000 Review, 1994. Hyattsville MD: Public Health Service, 1995. [DHHS Publication No. 95–125–61.]Google Scholar
  10. 10.
    US Public Health Service. Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Wkly Rep 1992; 41:RR-14.Google Scholar
  11. 11.
    Canadian Task Force on the Periodic Health Examination. 1994 update: 3. Primary and secondary prevention of neural tube defects. Can MedAssoc J 1994; 151:159–166.Google Scholar
  12. 12.
    Elwood M. Prevention of neural tube defects: clinical and public health policy. NZ Med J 1993; 106•517–518Google Scholar
  13. 13.
    Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown, 1987.Google Scholar
  14. 14.
    Kune S, Kune GA, Watson LE Case-control study of dietary etiological factors: The Melbourne Colorectal Cancer Study. Nutr Cancer 1987; 9:21–42.Google Scholar
  15. 15.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA 1993; 269:3015–3023.CrossRefGoogle Scholar
  16. 16.
    Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azern SP. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progress of coronary artery atherosclerosis. JAMA 1995; 273:1849–1854.CrossRefGoogle Scholar
  17. 17.
    Nielson GJ. Technical report: analysis of costs associated with the clinical use of nutritional supplements. Columbus, OH: Abbott Laboratories, 1993.Google Scholar
  18. 18.
    Cassel CK, Brody JA. Demograph, epidemiology, and aging. In: Geriatric Medicine, 2nd ed. Cassel CK, Riesenberg DE, Sorensen LB, Walsh JA, eds. New York: Springer Verlag, 1990; 16–27.Google Scholar
  19. 19.
    National Center for Health Statistics. Monthly Vital Statistics Report 1988; 37:April 25.Google Scholar
  20. 20.
    Fries JF, Green LW, Levine S. Health promotion and the compression of morbidity. Lancet 1989; 4:481–483.CrossRefGoogle Scholar
  21. 21.
    Havlick RJ, Feinleib M, eds. Proceedings of the conference on the decline in coronary heart disease mortality. Bethesda, MD: Public Health Service. [DHEW Publication No. (NIH). 1979:79–161].Google Scholar
  22. 22.
    Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J 1981; 282:1847–1851.CrossRefGoogle Scholar
  23. 23.
    Beaglehole R. Medical management and the decline in mortality from coronary heart disease. Br Med J 1986; 292:33–35.CrossRefGoogle Scholar
  24. 24.
    Gomez-Marin 0, Folsom AR, Kottke TE, Wu SC, Jacobs DR Jr, Gillum RF, Edlavitch SA, Blackburn H. Improvement in long-term survival among patients hospitalized with acute myocardial infarction: 1970 to 1980. New Engl J Med 1987; 316:1353–1359.CrossRefGoogle Scholar
  25. 25.
    Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in attack and survival among patients hospitalized with acute myocardial infarction (1975 through 1981). JAMA 1986; 255:2774–2779.CrossRefGoogle Scholar
  26. 26.
    Keaney JF, Frei B. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In: Natural Antioxidants in Human Health and Disease. Frei B, ed. San Diego: Academic Press, 1994; 303–352.Google Scholar
  27. 27.
    Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. Francis RB Jr, ed. New York: Marcel Dekker, 1992; 183–236.Google Scholar
  28. 28.
    Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14:32–38.CrossRefGoogle Scholar
  29. 29.
    Ballar JC, Smith EM. Progress against cancer. New Engl J Med 1986; 314:1226–1232.CrossRefGoogle Scholar
  30. 30.
    Eddy DM. Screening for lung cancer. Ann Intern Med 1989; 111:232–237.Google Scholar
  31. 31.
    The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and betacarotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994; 330:1029–1035.Google Scholar
  32. 32.
    Mayne ST, Janerich DT, Greenwald P, Chorost S, Tucci C, Zaman MB. Dietary beta carotene and lung cancer risk in U.S. nonsmokers. J Natl Cancer Inst 1994; 86:33–38.CrossRefGoogle Scholar
  33. 33.
    Ziegler R. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 1989; 119:116–122.Google Scholar
  34. 34.
    Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991; 54:270S–282S.Google Scholar
  35. 35.
    Knekt P. Epidemiology of vitamin E: evidence for anticancer effects in humans. In: Vitamin E in Health and Disease Packer L Fuchs J. eds. New York: Marcel Dekker. 1993 • 513–527.Google Scholar
  36. 36.
    Optimal calcium intake. NIH Consensus Statement 1994. Jun 6–8; 12(4):1–31.Google Scholar
  37. 37.
    Klag MJ, Whelton PK, Whelton AA. Decline in U.S. stroke mortality: demographic trends and antihypertensive treatment. Stroke 1989; 20:14–21.CrossRefGoogle Scholar
  38. 38.
    Kannel WB, Wolf PA. Epidemiology of cerebrovascular disease. In: Vascular Disease of the Central Nervous System. Russell RWR, ed. Edinburgh: Churchill Livingstone, 1983:1–24.Google Scholar
  39. 39.
    Bonita R, Beaglehole R. Does treatment of hypertension explain the decline in mortality from stroke? Br Med J 1986; 292:191,192.Google Scholar
  40. 40.
    Reed D, Yano K, Kagan A. Lipid and lipoproteins as predictors of coronary heart disease, stroke, and cancer in the Honolulu Heart Program. Am J Med 1986; 80:871–878.CrossRefGoogle Scholar
  41. 41.
    Tanaka H, Hayashi M, Date C, Imai K, Asada M, Shoji H, Okazake K, Yamamoto H, Yoshikawa K, Shimada T, Lee SI. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke 1985; 16:773–780.CrossRefGoogle Scholar
  42. 42.
    Snowden DA. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-Day Adventists. Am J Clin Nutr 1988; 48:739–748.Google Scholar
  43. 43.
    Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PWF, Belanger AJ, O’Leary AH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl J Med 1995; 332:286–291.CrossRefGoogle Scholar
  44. 44.
    US Department of Health and Human Services, National Diabetes Data Group. National Institute of Health. Public Health Service Diabetes in America: Diabetes data compiled 1984. National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases, 1985. [NIH Publ. No 85–14681.Google Scholar
  45. 45.
    Anderson RA. Chromium metabolism and its role in disease processes in man. Chem Physiol Biochem 1986; 4:31–41.Google Scholar
  46. 46.
    Paolisso G, Di Maro G, Galzerano D, Cacciapuotti F, Varricchio G, Varrichio M, D’onofrio F. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994; 59:1291–1296.Google Scholar
  47. 47.
    Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7:178–208.Google Scholar
  48. 48.
    Dawson-Hughes B, Krall EA, Harris S. Risk factors for bone loss in healthy postmenopausal women. Osteoporosis Intl 1993; 3:S27–S31.CrossRefGoogle Scholar
  49. 49.
    Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier, PJ. Vitamin D3 and calcium to prevent hip fractures in elderly women. New Engl J Med 1992; 327:1637–1642.CrossRefGoogle Scholar
  50. 50.
    Heikinheimo RJ, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, Hokko AM, Kolho LA, Rajala SA. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992; 51:105–110.CrossRefGoogle Scholar
  51. 51.
    Aloia JF, Vaswani A, Yeh JK, Ross PL, Faster E, Dilmanian FA. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Int Med 1994; 120:97–103.Google Scholar
  52. 52.
    Saltman PD, Strause LG. The role of trace minerals in osteoporosis. J Am Coll Nutr, 1993; 12:384–389.Google Scholar
  53. 53.
    Strause L, Saltman P, Smith KT, Bracker M, Andon MB. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994; 124:1060–1064.Google Scholar
  54. 54.
    Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnesium Trace Elements, 1990; 9:61–69.CrossRefGoogle Scholar
  55. 55.
    Blumberg JB. Vitamins. In: Diet, Nutrition, and Immunity. Forse RA, ed. Boca Raton, FL: CRC, 1994; 237–246.Google Scholar
  56. 56.
    Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subiects. Lancet 1992; 340:1124–1127.CrossRefGoogle Scholar
  57. 57.
    Bogden JD, Bendich A, Kemp FW, Bruening KS, Skurnick JH, Denny T, Baker H, Louria DB. Daily micronutrient supplements enhance delayed hypersensitivity skin test responses in older people. Am J Clin Nutr 1994; 60:437–447.Google Scholar
  58. 58.
    Jacques PF, Chylack LT Jr, Taylor A. Relationships between natural antioxidants and cataract formation. In: Natural Antioxidants in Human Health and Disease. Frei B, ed. San Diego: Academic, 1994; 515–533.Google Scholar
  59. 59.
    Sperduto RD, Hu T–S, Milton RC, Zhao JL, Everett DF, Cheng Q–F, Blot WJ, Bing L, Taylor PR, Jun-Yao L, Guo W–D. The Linxian Cataract Studies: two nutrition intervention trials. Arch Ophthalmol 1993; 111:1246–1253.CrossRefGoogle Scholar
  60. 60.
    West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S, Bressler NM. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 1994; 112:222–227.CrossRefGoogle Scholar
  61. 61.
    Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair HN, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994; 272:1413–1420.CrossRefGoogle Scholar
  62. 62.
    Goodwin JS, Goodwin JM, Garry, PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983; 249:2917–2921.CrossRefGoogle Scholar
  63. 63.
    Tucker DM, Penland JG, Sandstead HH, Milne DB, Heck DG, Klevay LM. Nutrition status and brain function in aging. Am J Clin Nutr 1990; 52:93–102.Google Scholar
  64. 64.
    Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14:32–38.CrossRefGoogle Scholar
  65. 65.
    Stehbens WE. The concept of cause in disease. J Chron Dis 1985; 38:947–950.CrossRefGoogle Scholar
  66. 66.
    Doll R, Hill AB. Mortality in relation to smoking: ten years’ observations of British doctors. Br Med J 1964; 1:1399–1410.CrossRefGoogle Scholar
  67. 67.
    Rose G. Incubation period of coronary heart disease. Br Med J 1982; 284:1600–1601.CrossRefGoogle Scholar
  68. 68.
    Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med 1993; 328:1450–1456.Google Scholar
  69. 69.
    Jalial I, Fuller CJ, Huet BA. The effect of a-tocopherol supplementation on LDL oxidation. Arteriosclerosis Thromb Vasc Biol 1995; 15:190–198.CrossRefGoogle Scholar
  70. 70.
    Gori G, Richter BS. Macroeconomics of disease prevention in the United States. Science 1978; 200:1124–1129.CrossRefGoogle Scholar
  71. 71.
    Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA 1990; 263:2335–2340.CrossRefGoogle Scholar
  72. 72.
    Fries JF. Aging, illness, and health policy: implication of the compression of morbidity. Perspect Biol Med 1988; 31:407–428.Google Scholar
  73. 73.
    Leaf A. Preventive medicine for our ailing health care system. JAMA 1993; 269:616–618.CrossRefGoogle Scholar
  74. 74.
    Olshansky SJ, Carnes BA, Cassel C. In search of Methuselah: estimating the upper limits to human longevity. Science 1990; 250:634–639.CrossRefGoogle Scholar
  75. 75.
    Fries JF. Reduction of the national morbidity. Gerontol Perspect 1987; 1:54–65.Google Scholar
  76. 76.
    Tarlov AR, Ware JE, Greenfield D, Nelson EC, Perin E, Zubkoff N. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA 1989; 262:925–930.CrossRefGoogle Scholar
  77. 77.
    Fries JF. Aging, natural death. and the compression of morbidity. New Engl J Med 1980; 303:130–136.CrossRefGoogle Scholar
  78. 78.
    Fries JF, Crapo LM. Vitality and Aging. New York: Freeman, 1981.Google Scholar
  79. 79.
    Fries JF. The compression of morbidity: miscellaneous comments about a heme. Gerontologist 1984; 24:354–359.CrossRefGoogle Scholar
  80. 80.
    Tornstam L. The quo vadis of gerontology: on the scientific paradigm of gerontology. Gerontologist 1992; 32:318–326.CrossRefGoogle Scholar
  81. 81.
    Olshandsky SJ, Rudberg MA, Carnes BA, Cassell CK, Brody JA. Trading off longer life for worsening health: the expansion of morbidity hypothesis. JAging Health 1991; 3:194–216.Google Scholar
  82. 82.
    Guralnick JM, LaCroix AZ, Branch LG, Kasi SV, Wallace RB. Morbidity and disability in older persons in the years prior to death. Am J Public Health 1991; 81:443–447.CrossRefGoogle Scholar
  83. 83.
    Rudberg MA, Cassel CK. Are death and disability in old age preventable? Fact Res Gerontol 1993; 7:191–201.Google Scholar
  84. 84.
    Multiple Risk Factor Intervention Trial Research Group. Coronary heart disease death, non-fatal acute myocardial infarction and other clinical outcomes in the multiple risk factor intervention trial. Am J Cardiol 1986;58:1–13.CrossRefGoogle Scholar
  85. 85.
    Tsevat J, Weinstein MC, Williams LW, Tosteson AN, Goldman L. Expected gains in life expectancy from various coronary heart disease risk modifications. Circulation 1991; 83:1194–1201.CrossRefGoogle Scholar
  86. 86.
    Fries JF, Tilton-Fries S, Parcell CL, Harrington H. Health risk changes with a low-cost individualized health promotion program: effects at up to 30 months. Am J Health Promotion 1992; 6:364–371.CrossRefGoogle Scholar
  87. 87.
    Leigh JP, Richardson N, Beck R, Kerr C, Harrington H, Parcell CL, Fries JF. Randomized controlled study of a retiree health promotion program: the Bank of America study. Arch Intern Med 1992; 152:1201–1206.CrossRefGoogle Scholar
  88. 88.
    Pelletier KR. A review and analysis of the health and cost-effective outcome studies of comprehensive health nromotion and disease nrevention program Am J Health Promotion 1991 • 5•311–313Google Scholar
  89. 89.
    Eisenberg DM, Kessler RC, Foster C, Norlack FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. New Engl J Med 1993; 328:246–252.CrossRefGoogle Scholar
  90. 90.
    National Academy of Sciences. Nutrition education in U.S. medical schools. Washington DC: National Academy Press, 1985.Google Scholar
  91. 91.
    Feldman EB. Networks for medical nutrition education―a review of the U.S. experience and future prospects. Am J Clin Nutr 1995; 62:512–517.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Jeffrey B. Blumberg

There are no affiliations available

Personalised recommendations